Abiopharma

Clinical trial NCT07431866: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT06515613 updates: 1. completion date: 2028-04-30 → 2028-12-31 2. primary completion date: 2027-04-30 → 2028-05-31 3. enrollment: 80 → 156 participants

Clinical trial NCT05626049: completion date: 2027-06-01 → 2027-06-30.

Clinical trial NCT05038735: enrollment: 234 → 210 participants.

Clinical trial NCT05688436: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07478211 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-07-31 → 2026-09-30 3. primary completion date: 2026-07-31 → 2026-09-30 4. enrollment type: ESTIMATED → ACTUAL 5. collaborators added: Fresenius Kabi (Schweiz) AG, DexCom, Inc., Bern Medtech Collaboration Call

Clinical trial NCT07361445: enrollment: 20 → 60 participants.

Clinical trial NCT07221981: enrollment: 1519 → 1708 participants.

Clinical trial NCT04624230 updates: 1. completion date: 2029-07-18 → 2029-07-04 2. primary completion date: 2027-04-28 → 2027-04-14

Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound